viloxazine has been researched along with methylphenidate in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Hajdukovic, R; Mitler, MM | 1 |
| Adewole, T; Faison, SL; Fry, N; Maletic, V; Nasser, A; Odebo, O; Schwabe, S; Wang, Z | 1 |
| Hafeez, S; Qureshi, NE; Saquib, J | 1 |
| Childress, A; Cutler, AJ; Fry, N; Hull, JT; Liranso, T; Nasser, A; Rubin, J | 1 |
| Balasundaram, MK; Singh, A | 1 |
3 trial(s) available for viloxazine and methylphenidate
| Article | Year |
|---|---|
Relative efficacy of drugs for the treatment of sleepiness in narcolepsy.
Topics: Adult; Arousal; Benzhydryl Compounds; Central Nervous System Stimulants; Codeine; Dextroamphetamine; Female; Humans; Male; Methylphenidate; Modafinil; Narcolepsy; Pemoline; Piperidines; Protriptyline; Reaction Time; Ritanserin; Sleep Stages; Sodium Oxybate; Viloxazine; Wakefulness | 1991 |
Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Methylphenidate in Healthy Adults.
Topics: Administration, Oral; Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cross-Over Studies; Delayed-Action Preparations; Female; Humans; Male; Methylphenidate; Middle Aged; Norepinephrine Plasma Membrane Transport Proteins; Viloxazine; Young Adult | 2021 |
Authors' Reply to Singh and Balasundaram: Comment on "A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder".
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Capsules; Central Nervous System Stimulants; Delayed-Action Preparations; Double-Blind Method; Humans; Methylphenidate; Viloxazine | 2022 |
3 other study(ies) available for viloxazine and methylphenidate
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Viloxazine: A new miracle drug for attention deficit hyperactivity disorder (ADHD) or just another non-stimulant?
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Humans; Methylphenidate; Pharmaceutical Preparations; Treatment Outcome; Viloxazine | 2022 |
Comment on: "A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention Deficit/Hyperactivity Disorder".
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Capsules; Central Nervous System Stimulants; Delayed-Action Preparations; Double-Blind Method; Humans; Methylphenidate; Viloxazine | 2022 |